John F. Carey - Feb 1, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, as attorney-in-fact
Stock symbol
TMDX
Transactions as of
Feb 1, 2023
Transactions value $
-$65,222
Form type
4
Date filed
2/3/2023, 04:12 PM
Previous filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $22K +1.36K +9.65% $16.14* 15.5K Feb 1, 2023 Direct F1
transaction TMDX Common Stock Options Exercise $1.81K +47 +0.3% $38.46 15.5K Feb 1, 2023 Direct F1
transaction TMDX Common Stock Sale -$36.1K -582 -3.75% $62.00 14.9K Feb 1, 2023 Direct F1, F2
transaction TMDX Common Stock Sale -$23.7K -379 -2.54% $62.52 14.6K Feb 1, 2023 Direct F1, F3
transaction TMDX Common Stock Sale -$6.15K -96 -0.66% $64.04 14.5K Feb 1, 2023 Direct F1, F4
transaction TMDX Common Stock Sale -$9.02K -139 -0.96% $64.88 14.3K Feb 1, 2023 Direct F1, F5
transaction TMDX Common Stock Sale -$14.1K -214 -1.49% $65.81 14.1K Feb 1, 2023 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -1.36K -21.81% $0.00 4.89K Feb 1, 2023 Common Stock 1.36K $16.14 Direct F1, F7
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -47 -0.35% $0.00 13.5K Feb 1, 2023 Common Stock 47 $38.46 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John F. Carey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
F8 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Remarks:

The reporting person is no longer subject to Section 16 in connection with his transactions in securities of the Company and therefore will no longer report any such transactions on Form 4 or Form 5.